vs
CODEXIS, INC.（CDXS）与FutureFuel Corp.（FF）财务数据对比。点击上方公司名可切换其他公司
CODEXIS, INC.的季度营收约是FutureFuel Corp.的2.0倍（$38.9M vs $19.8M）。CODEXIS, INC.净利率更高（24.7% vs -60.5%，领先85.2%）。CODEXIS, INC.同比增速更快（81.3% vs -67.7%）。CODEXIS, INC.自由现金流更多（$19.6M vs $-29.9M）。过去两年CODEXIS, INC.的营收复合增速更高（51.0% vs -41.7%）
科迪西斯是一家专注于蛋白质工程的企业，核心业务是开发可应用于制药、食品及医疗领域的酶制剂，依托自身技术优势为相关行业提供高性能的生物催化解决方案，助力生命科学与食品加工领域的技术升级。
FutureFuel是一家专注于化学品与生物燃料的研发生产商，业务涵盖相关产品的开发与生产，目前在纽约证券交易所挂牌上市，股票代码为FF。
CDXS vs FF — 直观对比
营收规模更大
CDXS
是对方的2.0倍
$19.8M
营收增速更快
CDXS
高出149.1%
-67.7%
净利率更高
CDXS
高出85.2%
-60.5%
自由现金流更多
CDXS
多$49.4M
$-29.9M
两年增速更快
CDXS
近两年复合增速
-41.7%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $38.9M | $19.8M |
| 净利润 | $9.6M | $-12.0M |
| 毛利率 | 94.8% | -46.7% |
| 营业利润率 | 27.1% | -62.9% |
| 净利率 | 24.7% | -60.5% |
| 营收同比 | 81.3% | -67.7% |
| 净利润同比 | 192.5% | -529.4% |
| 每股收益（稀释后） | $0.13 | $-0.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CDXSFF
| Q4 25 | $38.9M | $19.8M | ||
| Q3 25 | $8.6M | $22.7M | ||
| Q2 25 | $15.3M | $35.7M | ||
| Q1 25 | $7.5M | $17.5M | ||
| Q4 24 | $21.5M | $61.5M | ||
| Q3 24 | $12.8M | $51.1M | ||
| Q2 24 | $8.0M | $72.4M | ||
| Q1 24 | $17.1M | $58.3M |
净利润CDXSFF
| Q4 25 | $9.6M | $-12.0M | ||
| Q3 25 | $-19.6M | $-9.3M | ||
| Q2 25 | $-13.3M | $-10.4M | ||
| Q1 25 | $-20.7M | $-17.6M | ||
| Q4 24 | $-10.4M | $2.8M | ||
| Q3 24 | $-20.6M | $-1.2M | ||
| Q2 24 | $-22.8M | $9.6M | ||
| Q1 24 | $-11.5M | $4.3M |
毛利率CDXSFF
| Q4 25 | 94.8% | -46.7% | ||
| Q3 25 | 71.3% | -30.1% | ||
| Q2 25 | 86.3% | -24.6% | ||
| Q1 25 | 63.8% | -83.0% | ||
| Q4 24 | 83.0% | 9.1% | ||
| Q3 24 | 66.4% | 0.7% | ||
| Q2 24 | 56.6% | 12.0% | ||
| Q1 24 | 71.6% | 8.6% |
营业利润率CDXSFF
| Q4 25 | 27.1% | -62.9% | ||
| Q3 25 | -220.3% | -42.9% | ||
| Q2 25 | -83.9% | -33.4% | ||
| Q1 25 | -271.6% | -107.4% | ||
| Q4 24 | -34.2% | 2.6% | ||
| Q3 24 | -129.0% | -5.6% | ||
| Q2 24 | -284.9% | 7.5% | ||
| Q1 24 | -69.6% | 3.8% |
净利率CDXSFF
| Q4 25 | 24.7% | -60.5% | ||
| Q3 25 | -228.1% | -41.1% | ||
| Q2 25 | -86.6% | -29.2% | ||
| Q1 25 | -274.3% | -100.6% | ||
| Q4 24 | -48.4% | 4.5% | ||
| Q3 24 | -160.8% | -2.3% | ||
| Q2 24 | -285.2% | 13.2% | ||
| Q1 24 | -67.4% | 7.4% |
每股收益（稀释后）CDXSFF
| Q4 25 | $0.13 | $-0.28 | ||
| Q3 25 | $-0.22 | $-0.21 | ||
| Q2 25 | $-0.16 | $-0.24 | ||
| Q1 25 | $-0.25 | $-0.40 | ||
| Q4 24 | $-0.12 | $0.06 | ||
| Q3 24 | $-0.29 | $-0.03 | ||
| Q2 24 | $-0.32 | $0.22 | ||
| Q1 24 | $-0.16 | $0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $78.2M | $51.3M |
| 总债务越低越好 | $40.1M | — |
| 股东权益账面价值 | $50.5M | $154.7M |
| 总资产 | $147.8M | $192.2M |
| 负债/权益比越低杠杆越低 | 0.79× | — |
8季度趋势，按日历期对齐
现金及短期投资CDXSFF
| Q4 25 | $78.2M | $51.3M | ||
| Q3 25 | $58.7M | $85.6M | ||
| Q2 25 | $66.3M | $95.2M | ||
| Q1 25 | $59.8M | $97.1M | ||
| Q4 24 | $73.5M | $109.5M | ||
| Q3 24 | $90.3M | $133.4M | ||
| Q2 24 | $73.2M | $115.1M | ||
| Q1 24 | $85.5M | $201.1M |
总债务CDXSFF
| Q4 25 | $40.1M | — | ||
| Q3 25 | $39.7M | — | ||
| Q2 25 | $39.4M | — | ||
| Q1 25 | $29.2M | — | ||
| Q4 24 | $28.9M | — | ||
| Q3 24 | $28.6M | — | ||
| Q2 24 | $28.4M | — | ||
| Q1 24 | $28.1M | — |
股东权益CDXSFF
| Q4 25 | $50.5M | $154.7M | ||
| Q3 25 | $38.5M | $169.1M | ||
| Q2 25 | $55.6M | $178.2M | ||
| Q1 25 | $49.6M | $188.4M | ||
| Q4 24 | $66.9M | $205.8M | ||
| Q3 24 | $73.4M | $213.3M | ||
| Q2 24 | $61.4M | $214.4M | ||
| Q1 24 | $79.3M | $204.8M |
总资产CDXSFF
| Q4 25 | $147.8M | $192.2M | ||
| Q3 25 | $124.0M | $203.5M | ||
| Q2 25 | $138.2M | $218.2M | ||
| Q1 25 | $128.9M | $227.7M | ||
| Q4 24 | $149.0M | $247.7M | ||
| Q3 24 | $148.2M | $256.5M | ||
| Q2 24 | $132.0M | $261.2M | ||
| Q1 24 | $149.6M | $365.4M |
负债/权益比CDXSFF
| Q4 25 | 0.79× | — | ||
| Q3 25 | 1.03× | — | ||
| Q2 25 | 0.71× | — | ||
| Q1 25 | 0.59× | — | ||
| Q4 24 | 0.43× | — | ||
| Q3 24 | 0.39× | — | ||
| Q2 24 | 0.46× | — | ||
| Q1 24 | 0.35× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $20.1M | $-27.4M |
| 自由现金流经营现金流 - 资本支出 | $19.6M | $-29.9M |
| 自由现金流率自由现金流/营收 | 50.3% | -150.5% |
| 资本支出强度资本支出/营收 | 1.3% | 12.2% |
| 现金转化率经营现金流/净利润 | 2.09× | — |
| 过去12个月自由现金流最近4个季度 | $-23.8M | $-46.0M |
8季度趋势，按日历期对齐
经营现金流CDXSFF
| Q4 25 | $20.1M | $-27.4M | ||
| Q3 25 | $-7.7M | $-1.1M | ||
| Q2 25 | $-18.0M | $5.2M | ||
| Q1 25 | $-13.8M | $-5.4M | ||
| Q4 24 | $-16.5M | $-16.6M | ||
| Q3 24 | $-13.0M | $25.8M | ||
| Q2 24 | $-12.2M | $27.8M | ||
| Q1 24 | $-7.8M | $-12.2M |
自由现金流CDXSFF
| Q4 25 | $19.6M | $-29.9M | ||
| Q3 25 | $-7.9M | $-6.5M | ||
| Q2 25 | $-20.5M | $-263.0K | ||
| Q1 25 | $-15.1M | $-9.4M | ||
| Q4 24 | $-18.2M | $-20.7M | ||
| Q3 24 | $-14.0M | $20.5M | ||
| Q2 24 | $-12.6M | $24.8M | ||
| Q1 24 | $-8.9M | $-14.5M |
自由现金流率CDXSFF
| Q4 25 | 50.3% | -150.5% | ||
| Q3 25 | -91.7% | -28.5% | ||
| Q2 25 | -133.6% | -0.7% | ||
| Q1 25 | -199.6% | -53.6% | ||
| Q4 24 | -85.0% | -33.6% | ||
| Q3 24 | -109.0% | 40.1% | ||
| Q2 24 | -157.5% | 34.3% | ||
| Q1 24 | -52.2% | -24.9% |
资本支出强度CDXSFF
| Q4 25 | 1.3% | 12.2% | ||
| Q3 25 | 2.1% | 23.5% | ||
| Q2 25 | 16.4% | 15.3% | ||
| Q1 25 | 16.7% | 22.8% | ||
| Q4 24 | 8.3% | 6.6% | ||
| Q3 24 | 7.8% | 10.4% | ||
| Q2 24 | 5.0% | 4.1% | ||
| Q1 24 | 6.6% | 3.9% |
现金转化率CDXSFF
| Q4 25 | 2.09× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -5.94× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 2.90× | ||
| Q1 24 | — | -2.82× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CDXS
暂无分部数据
FF
| Chemicals | $18.0M | 91% |
| Biofuels | $1.8M | 9% |
